Kelly Whelan became CEO of BioElectronics Corporation on November 15, 2019.
2017: First OTC clearance (limited indications)
2019: RecoveryRx clearance.This was on July 1, 2019.
2020: Major expanded clearance (all musculoskeletal pain)This was on Feb 3, 2020.
“Be kinder than necessary, for everyone you meet is fighting some kind of battle.”
James M.Barrie